Sanofi ADR (0A2V)
LSE
Closed
Oct 8, 2026
Day's Range
39.5952 wk Range
39.19Overview - 0A2V - Sanofi ADR
Key Statistics
Valuation
Enterprise Value
164.11B
P/E (Trailing)
‪13.73‬
P/E (Forward)
‪11.21‬
PEG Ratio
‪11.21‬
Price / Sales (TTM)
‪2.84‬
Price / Book
‪1.70‬
EV / EBITDA
‪10.24‬
Profitability
Gross Margin
‪75.47%‬
Profit Margin
‪18.71%‬
Operating Margin
‪23.87%‬
Return on Assets
‪5.55%‬
Return on Equity
‪12.06%‬
Ownership
Shares Outstanding
1.21B
Float
2.21B
Held by Insiders
‪0.0060%‬
Held by Institutions
‪10.63%‬
Price stats
Beta
‪0.42‬
50-Day Avg
‪43.87‬
200-Day Avg
‪45.23‬
Dividends
Payout Ratio
‪51.70%‬
Frequency
Annual
Market Cap - 0A2V - Sanofi ADR
Peers - 0A2V - Sanofi ADR
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on LSE.
Profile Summary - 0A2V - Sanofi ADR
About
Sanofi ADR is an American Depositary Receipt representing shares of Sanofi, a global healthcare company focused on pharmaceuticals and vaccines. Through its ADR program, U.S. investors can access the company’s ordinary shares in a form that is traded in the United States, while the underlying business remains centered…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
